<DOC>
	<DOC>NCT01737099</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.</brief_summary>
	<brief_title>Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>ages 1879 fasting TG levels, 150499 mg/dL baseline DHA intake &lt;200mg/d active and in good health recent diagnosis of CHD or history of revascularization within 6mos of study use of lipid altering medications (other than stable statins) use of anticoagulants use of omega3 products within 4 weeks of screening serum AST/ALT &gt;1.5x ULN and/or creatinine &gt;1.5 mg/dL at screening lipid altering foods or supplements women who are pregnant or of childbearing potential not using adequate birth control current use or history of drug or alcohol abuse inability to swallow capsules</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>omega-3</keyword>
	<keyword>DHA</keyword>
	<keyword>triglycerides</keyword>
	<keyword>lipids</keyword>
	<keyword>cardiovascular</keyword>
	<keyword>hypertriglyceridemia</keyword>
</DOC>